Видео ютуба по тегу Medicines: Atezolizumab

FDA D.I.S.C.O. Burst Edition: FDA approval of Tecentriq (atezolizumab) for adjuvant treatment fol...
FDA D.I.S.C.O. Burst Edition: FDA approval of Tecentriq (atezolizumab) for adjuvant treatment fol...
TACOS: A Phase 2 Trial of Atezolizumab and Cabozantinib in OsteoSarcoma
TACOS: A Phase 2 Trial of Atezolizumab and Cabozantinib in OsteoSarcoma
Tecentriq (atezolizumab) - Drug Rx Information
Tecentriq (atezolizumab) - Drug Rx Information
Overview of 2nd line treatment options in advanced HCC
Overview of 2nd line treatment options in advanced HCC
ഏഴു മിനിറ്റിൽ ഒരു ഇൻജക്ഷൻ, കാൻസറിന് അതിവേഗ ചികിത്സ | Atezolizumab 7-Minute Cancer Treatment
ഏഴു മിനിറ്റിൽ ഒരു ഇൻജക്ഷൻ, കാൻസറിന് അതിവേഗ ചികിത്സ | Atezolizumab 7-Minute Cancer Treatment
ঐতিহাসিক খবর, ​7 মিনিটে ক্যানসার সারানোর ইনজেকশন এলো বাজারে​ | Atezolizumab | Cancer Treatment
ঐতিহাসিক খবর, ​7 মিনিটে ক্যানসার সারানোর ইনজেকশন এলো বাজারে​ | Atezolizumab | Cancer Treatment
IMbrave050: adjuvant atezolizumab with bevacizumab in high-risk HCC
IMbrave050: adjuvant atezolizumab with bevacizumab in high-risk HCC
CDSCO Panel Nod To Roche Anti Cancer Drug Atezolizumab For Metastatic Triple Negative Breast Cancer
CDSCO Panel Nod To Roche Anti Cancer Drug Atezolizumab For Metastatic Triple Negative Breast Cancer
FDA approves Atezolizumab as Adjuvant Treatment for Non-small Cell Lung Cancer
FDA approves Atezolizumab as Adjuvant Treatment for Non-small Cell Lung Cancer
FOLFOXIRI + bevacizumab + atezolizumab versus FOLFOXIRI + bevacizumab as first-line treatment of...
FOLFOXIRI + bevacizumab + atezolizumab versus FOLFOXIRI + bevacizumab as first-line treatment of...
Atezolizumab With Chemotherapy in First-line Treatment of Non-squamous NSCLC
Atezolizumab With Chemotherapy in First-line Treatment of Non-squamous NSCLC
ESMO 2020 Expert Video report on atezolizumab in upfront treatment of TNBC
ESMO 2020 Expert Video report on atezolizumab in upfront treatment of TNBC
Dr Melissa Johnson: Tiragolumab/Atezolizumab Potential New Treatment Option for NSCLC
Dr Melissa Johnson: Tiragolumab/Atezolizumab Potential New Treatment Option for NSCLC
Evaluating the combination of atezolizumab with neoadjuvant chemotherapy for the treatment of tr...
Evaluating the combination of atezolizumab with neoadjuvant chemotherapy for the treatment of tr...
pCR to neoadjuvant treatment with or without atezolizumab in early HR TNBC
pCR to neoadjuvant treatment with or without atezolizumab in early HR TNBC
Atezolizumab and bevacizumab for upfront unresectable HCC
Atezolizumab and bevacizumab for upfront unresectable HCC
Study of Atezolizumab with Pertuzumab and Trastuzumab in HER2- Positive Metastatic Breast Cancer
Study of Atezolizumab with Pertuzumab and Trastuzumab in HER2- Positive Metastatic Breast Cancer
Molecular Targeted Therapies for Advanced HCC
Molecular Targeted Therapies for Advanced HCC
Olaparib Alone or in Comb. w Atezolizumab in Treatment of Patients with HER2- BRCAmt Breast Cancer
Olaparib Alone or in Comb. w Atezolizumab in Treatment of Patients with HER2- BRCAmt Breast Cancer